$INVU
Investview, Inc. Stock $invu

$invu Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000149315224011916 Filed on March 29, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$15.67M	$17.93M	$67.92M
YoY Change	15.52%	25.02%	9.82%
Cost Of Revenue	$2.142M	$3.122M	$10.74M
YoY Change	14.08%	31.36%	30.15%
Gross Profit	$13.53M	$14.80M	$57.18M
YoY Change	15.75%	23.76%	6.69%
Gross Profit Margin	86.33%	82.59%	84.19%
Selling, General & Admin	$11.80K	$11.95M	$50.30M
YoY Change	-95.33%	-2.33%	85709.95%
% of Gross Profit	0.09%	80.7%	87.96%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.178M	$1.190M	$4.450M
YoY Change	21.3%	-39.78%	-28.54%
% of Gross Profit	8.71%	8.04%	7.78%
Operating Expenses	$13.80M	$11.95M	$50.30M
YoY Change	4.76%	-2.33%	-28.61%
Operating Profit	$1.870M	$2.857M	$6.885M
YoY Change	376.7%	-1153.25%	-179.94%
Interest Expense	-$38.05K	-$227.4K	-$984.4K
YoY Change	-112.32%	-58.44%	-76.56%
% of Operating Profit	-2.03%	-7.96%	-14.3%
Other Income/Expense, Net	$299.6K	$362.7K	$1.390M
YoY Change	170.92%	324.15%	-134.7%
Pretax Income	$2.170M	$896.1K	$5.010M
YoY Change	331.45%	-105.79%	-139.71%
Income Tax	$500.1K	$1.078M	$2.178M
% Of Pretax Income	23.04%	120.28%	43.48%
Net Earnings	$1.670M	-$386.5K	$2.013M
YoY Change	309.41%	-97.5%	-115.55%
Net Earnings / Revenue	10.66%	-2.16%	2.96%
Basic Earnings Per Share	$0.00		$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	1.861B shares	2.333B shares	2.559B shares
Diluted Shares Outstanding	3.089B shares		3.596B shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$24.43M	$20.91M	$20.91M
YoY Change	27.02%	2.17%	2.17%
Cash & Equivalents	$24.43M	$20.91M	$20.91M
Short-Term Investments
Other Short-Term Assets	$232.8K	$1.309M	$1.309M
YoY Change	-88.8%	-44.57%	-62.71%
Inventory	$0.00	$0.00	$0.00
Prepaid Expenses	$643.8K	$492.6K
Receivables	$1.873M	$2.233M	$2.233M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$27.80M	$24.45M	$24.45M
YoY Change	10.4%	-6.01%	-6.01%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.361M	$6.647M	$6.647M
YoY Change	-34.25%	-21.87%	-23.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$2.589M	$2.588M	$2.588M
YoY Change	-2.98%	446.48%	446.48%
Other Assets	$2.675M	$0.00	$0.00
YoY Change	-9.91%	-100.0%	-100.0%
Total Long-Term Assets	$8.036M	$9.235M	$9.235M
YoY Change	-27.75%	-3.38%	-3.38%
TOTAL ASSETS
Total Short-Term Assets	$27.80M	$24.45M	$24.45M
Total Long-Term Assets	$8.036M	$9.235M	$9.235M
Total Assets	$35.84M	$33.69M	$33.69M
YoY Change	-1.29%	-5.3%	-5.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.399M	$5.854M	$5.854M
YoY Change	83.57%	27.02%	27.02%
Accrued Expenses	$206.6K	$297.1K	$297.1K
YoY Change	-2.4%	-14.03%	-14.03%
Deferred Revenue	$2.707M	$2.703M
YoY Change	0.66%	30.31%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$569.4K	$715.1K	$715.1K
YoY Change	-80.62%	-75.67%	-75.67%
Total Short-Term Liabilities	$14.84M	$12.04M	$12.04M
YoY Change	21.86%	2.31%	2.31%
LONG-TERM LIABILITIES
Long-Term Debt	$498.4K	$501.1K	$501.1K
YoY Change	-89.61%	-90.94%	-90.94%
Other Long-Term Liabilities	$1.247M	$2.358M	$2.358M
YoY Change	37.31%	160.84%	160.84%
Total Long-Term Liabilities	$3.880M	$2.859M	$2.859M
YoY Change	-32.87%	-55.56%	-55.56%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.84M	$12.04M	$12.04M
Total Long-Term Liabilities	$3.880M	$2.859M	$2.859M
Total Liabilities	$18.72M	$14.90M	$14.90M
YoY Change	4.25%	-18.15%	-18.15%
SHAREHOLDERS EQUITY
Retained Earnings	-$86.11M	-$87.58M
YoY Change	-3.66%	-2.25%
Common Stock	$1.861M	$2.333M
YoY Change	-29.41%	-11.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$17.12M	$18.79M	$18.79M
YoY Change
Total Liabilities & Shareholders Equity	$35.84M	$33.69M	$33.69M
YoY Change	-1.29%	-5.3%	-5.3%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$1.670M	-$386.5K	$2.013M
YoY Change	309.41%	-97.5%	-115.55%
Depreciation, Depletion And Amortization	$1.178M	$1.190M	$4.450M
YoY Change	21.3%	-39.78%	-28.54%
Cash From Operating Activities	$4.800M	$265.3K	$6.065M
YoY Change	-1303.96%	-86.91%	-35.2%
INVESTING ACTIVITIES
Capital Expenditures	$2.903K	$31.00K	$2.561M
YoY Change	-99.53%	1106.23%	-83.23%
Acquisitions
YoY Change
Other Investing Activities		$3.280K	$23.28K
YoY Change		-93.32%	-97.87%
Cash From Investing Activities	-$2.903K	-$27.72K	-$2.538M
YoY Change	-99.53%	-159.63%	-82.1%
FINANCING ACTIVITIES
Cash Dividend Paid	$174.8K		$627.9K
YoY Change	8.85%		0.17%
Common Stock Issuance & Retirement, Net			-$396.5K
YoY Change			-948.72%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$1.357M	-1.994M	-3.874M
YoY Change	116.71%	196.58%	-38.65%
NET CHANGE
Cash From Operating Activities	$4.800M	265.3K	6.065M
Cash From Investing Activities	-$2.903K	-27.72K	-2.538M
Cash From Financing Activities	-$1.357M	-1.994M	-3.874M
Net Change In Cash	$3.440M	-1.756M	-346.3K
YoY Change	-309.4%	-225.42%	-96.89%
FREE CASH FLOW
Cash From Operating Activities	$4.800M	$265.3K	$6.065M
Capital Expenditures	$2.903K	$31.00K	$2.561M
Free Cash Flow	$4.797M	$234.3K	$3.504M
YoY Change	-571.93%	-88.42%	-159.32%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000862651
CY2023Q4	us-gaap	Inventory Net InventoryNet		usd
CY2023Q4	INVU	Income Tax Paid In Advance IncomeTaxPaidInAdvance		usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent		usd
CY2023Q4	us-gaap	Other Restricted Assets Noncurrent OtherRestrictedAssetsNoncurrent		usd
CY2023Q4	INVU	Customer Advance Current CustomerAdvanceCurrent		usd
CY2022Q4	INVU	Accrued Liabilities Long Term AccruedLiabilitiesLongTerm		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax		usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax		usd
CY2022	INVU	Common Stock Canceled CommonStockCanceled		usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2022	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets		usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
CY2023	INVU	Common Stock Cancelled CommonStockCancelled		usd
CY2022	INVU	Common Stock Repurchased For Payables CommonStockRepurchasedForPayables		usd
CY2022	INVU	Cryptocurrency Received From Sale Of Fixed Assets CryptocurrencyReceivedFromSaleOfFixedAssets		usd
CY2022	INVU	Derivative Liability Extinguished With Warrant Exercise DerivativeLiabilityExtinguishedWithWarrantExercise		usd
CY2023	INVU	Contribution Of Crypto Currency From Related Party ContributionOfCryptoCurrencyFromRelatedParty		usd
CY2023	INVU	Fixed Assets Moved To Inventory FixedAssetsMovedToInventory		usd
CY2023	INVU	Fixed Asset Acquired FixedAssetAcquired		usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent		usd
CY2023Q4	us-gaap	Property Plant And Equipment Useful Life Description Of Term Extensible Enumeration PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration	http://fasb.org/us-gaap/2023#LeaseholdImprovementsMember
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue		usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue		usd
CY2023Q4	INVU	Customer Advance Current CustomerAdvanceCurrent		usd
CY2023Q4	us-gaap	Inventory Net InventoryNet		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2022	INVU	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Exercise Price Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2022	INVU	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Exercise Price Canceled ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceCanceled
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2022	INVU	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Exercise Price Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2023	INVU	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Exercise Price Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2023	INVU	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Exercise Price Canceled ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceCanceled
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign		usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign		usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit		usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit		usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Fdii Amount EffectiveIncomeTaxRateReconciliationFdiiAmount		usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	75133858	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1860981786	shares
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	2738
CY2023	dei	Auditor Name AuditorName	M&K CPAS, PLLC
CY2023	dei	Auditor Location AuditorLocation	The Woodlands, TX
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20912276	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20317253	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	230354	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	931540	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	492607	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	366561	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	2232725	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	1255542	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	249480	usd
CY2022Q4	INVU	Income Tax Paid In Advance IncomeTaxPaidInAdvance	535932	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	585632	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2360957	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	24453594	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	26017265	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6536823	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8508274	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	240105	usd
CY2022Q4	us-gaap	Other Restricted Assets Noncurrent OtherRestrictedAssetsNoncurrent	113139	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	110427	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	223692	usd
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2333356496	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2333356496	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2636275489	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2636275489	shares
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	2588127	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	473598	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2698554	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1050534	usd
CY2023Q4	us-gaap	Assets Assets	33688971	usd
CY2022Q4	us-gaap	Assets Assets	35576073	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	5854093	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4608786	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	187419	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	197300	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1004535	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	240603	usd
CY2022Q4	INVU	Customer Advance Current CustomerAdvanceCurrent	96609	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2703398	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2074574	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	5732	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	24426	usd
CY2023Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	256392	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	236630	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	109628	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	148226	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1203247	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1201927	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	715127	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2938757	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12039571	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11767838	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6048	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	79432	usd
CY2023Q4	INVU	Accrued Liabilities Long Term AccruedLiabilitiesLongTerm	1189643	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1162349	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	824581	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	501062	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	5529646	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2859102	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	6433659	usd
CY2023Q4	us-gaap	Liabilities Liabilities	14898673	usd
CY2022Q4	us-gaap	Liabilities Liabilities	18201497	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	252192	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	252192	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	252192	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	252192	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	252	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	252	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2333356	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2636275	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	104056807	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	104350746	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-23218	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-23218	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-87576899	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-89589479	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	18790298	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	17374576	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	33688971	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35576073	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	67920871	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	61848904	usd
CY2023	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	10736709	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	8249790	usd
CY2023	INVU	Commissions Commissions	31716399	usd
CY2022	INVU	Commissions Commissions	26986048	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	560065	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	58617	usd
CY2023	us-gaap	Salaries And Wages SalariesAndWages	7112954	usd
CY2022	us-gaap	Salaries And Wages SalariesAndWages	7441829	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	14632823	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3975	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-223630	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9531431	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	455	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	18691	usd
CY2023	INVU	Realized Gain Loss On Cryptocurrency RealizedGainLossOnCryptocurrency	255268	usd
CY2022	INVU	Realized Gain Loss On Cryptocurrency RealizedGainLossOnCryptocurrency	-1575164	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1389796	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	193235	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	405402	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4005603	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5010332	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12618389	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2178412	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	326555	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2831920	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-12944944	usd
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	819340	usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	819340	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2012580	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13764284	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-218	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-218	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2831920	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12945162	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2559093504	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2677718626	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3595522075	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2677718626	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	28939841	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2784145	usd
CY2022	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	46720	usd
CY2022	INVU	Stock Repurchased And Retired From Related Parties During Period Value StockRepurchasedAndRetiredFromRelatedPartiesDuringPeriodValue	-1724009	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	1185821	usd
CY2022	us-gaap	Dividends Dividends	819340	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-218	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-12944944	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	17374576	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	17374576	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2575496	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	23	usd
CY2023	INVU	Adjustments To Additional Paid In Capital Derivative Liability Extinguished For Warrants Exercised AdjustmentsToAdditionalPaidInCapitalDerivativeLiabilityExtinguishedForWarrantsExercised	3	usd
CY2023	INVU	Stock Repurchased And Retired From Related Parties During Period Value StockRepurchasedAndRetiredFromRelatedPartiesDuringPeriodValue	-3172380	usd
CY2023	us-gaap	Dividends Dividends	819340	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2831920	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	18790298	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	18790298	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2831920	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-12944944	usd
CY2023	us-gaap	Depreciation Depreciation	4450466	usd
CY2022	us-gaap	Depreciation Depreciation	6227907	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	337767	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1728862	usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	2575496	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	2784145	usd
CY2023	INVU	Gain Losson Lease Cost Netof Repayment GainLossonLeaseCostNetofRepayment	-1283	usd
CY2022	INVU	Gain Losson Lease Cost Netof Repayment GainLossonLeaseCostNetofRepayment	30542	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	455	usd
CY2023	INVU	Gain Loss On Disposal Of Fixed Assets GainLossOnDisposalOfFixedAssets	-223630	usd
CY2022	INVU	Gain Loss On Disposal Of Fixed Assets GainLossOnDisposalOfFixedAssets	266838	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	18691	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	44945	usd
CY2023	INVU	Realized Gain Loss On Cryptocurrency RealizedGainLossOnCryptocurrency	255268	usd
CY2022	INVU	Realized Gain Loss On Cryptocurrency RealizedGainLossOnCryptocurrency	-1575164	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3975	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2056386	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	14632823	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	977183	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-660552	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-74645	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	304655	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	126046	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	202307	usd
CY2023	INVU	Increase Decrease In Income Tax Paid In Advance IncreaseDecreaseInIncomeTaxPaidInAdvance	535932	usd
CY2022	INVU	Increase Decrease In Income Tax Paid In Advance IncreaseDecreaseInIncomeTaxPaidInAdvance	-535932	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	5396521	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	3827504	usd
CY2023	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	2114529	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-350764	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	725256	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	763932	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-567224	usd
CY2023	INVU	Increase Decrease Customer Advances IncreaseDecreaseCustomerAdvances	-96609	usd
CY2022	INVU	Increase Decrease Customer Advances IncreaseDecreaseCustomerAdvances	20907	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	628824	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1213869	usd
CY2023	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	18750	usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	18750	usd
CY2023	INVU	Increase Decrease In Interest Payable Related Parties Net IncreaseDecreaseInInterestPayableRelatedPartiesNet	901837	usd
CY2022	INVU	Increase Decrease In Interest Payable Related Parties Net IncreaseDecreaseInInterestPayableRelatedPartiesNet	921462	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6065257	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9360588	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	23278	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1093556	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2561001	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15267932	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2537723	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14174376	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	900516	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	2943272	usd
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	1948906	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	973217	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	46720	usd
CY2023	INVU	Payments For Shares Repurchased From Related Parties PaymentsForSharesRepurchasedFromRelatedParties	396547	usd
CY2022	INVU	Payments For Shares Repurchased From Related Parties PaymentsForSharesRepurchasedFromRelatedParties	1724009	usd
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends	627856	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	626784	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	23	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3873802	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6314002	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-218	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-346268	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11128008	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	21488898	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	32616906	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	21142630	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	21488898	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	932197	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	1060582	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	878548	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1429711	usd
CY2023	us-gaap	Notes Issued1 NotesIssued1	5322058	usd
CY2022	us-gaap	Notes Issued1 NotesIssued1	1979789	usd
CY2022	INVU	Common Stock Cancelled CommonStockCancelled	219833	usd
CY2023	INVU	Common Stock Repurchased For Payables CommonStockRepurchasedForPayables	2775833	usd
CY2023	INVU	Dividends Declared DividendsDeclared	-819340	usd
CY2022	INVU	Dividends Declared DividendsDeclared	-819340	usd
CY2023	INVU	Dividends Paid With Cryptocurrency DividendsPaidWithCryptocurrency	171722	usd
CY2022	INVU	Dividends Paid With Cryptocurrency DividendsPaidWithCryptocurrency	175631	usd
CY2023	INVU	Recognition Of Lease Liability And Rou Asset At Lease Commencement RecognitionOfLeaseLiabilityAndROUAssetAtLeaseCommencement	23520	usd
CY2022	INVU	Recognition Of Lease Liability And Rou Asset At Lease Commencement RecognitionOfLeaseLiabilityAndROUAssetAtLeaseCommencement	172042	usd
CY2023	INVU	Cryptocurrency Received From Sale Of Fixed Assets CryptocurrencyReceivedFromSaleOfFixedAssets	9913	usd
CY2023	INVU	Derivative Liability Extinguished With Warrant Exercise DerivativeLiabilityExtinguishedWithWarrantExercise	3	usd
CY2022	INVU	Contribution Of Crypto Currency From Related Party ContributionOfCryptoCurrencyFromRelatedParty	1185821	usd
CY2022	INVU	Fixed Assets Moved To Inventory FixedAssetsMovedToInventory	621093	usd
CY2022	INVU	Fixed Asset Acquired FixedAssetAcquired	259916	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_800_eus-gaap--NatureOfOperations_zxdImRdkLHn1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_822_zm2ct9cVOWZ8">ORGANIZATION AND NATURE OF BUSINESS </span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Organization</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investview, Inc. was incorporated on <span id="xdx_90B_edei--EntityIncorporationDateOfIncorporation_dd_c20230101__20231231_zQme7P0qiW27" title="Entity incorporation, date of incorporation">January 30, 1946</span>, under the laws of the state of Utah as the Uintah Mountain Copper Mining Company. In January 2005, we changed domicile to Nevada and changed our name to Voxpath Holding, Inc. In September of 2006, we merged with The Retirement Solution Inc. and then changed our name to TheRetirementSolution.Com, Inc. Subsequently, in October 2008 we changed our name to Global Investor Services, Inc., before changing our name to Investview, Inc., on March 27, 2012.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective April 1, 2017, we closed on a Contribution Agreement with the members of Wealth Generators, LLC, a limited liability company (“Wealth Generators”), pursuant to which the Wealth Generators members contributed <span id="xdx_900_ecustom--PercentageOnContributedShares_pid_dp_uPure_c20170329__20170401__us-gaap--TypeOfArrangementAxis__custom--ContributionAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--WealthGeneratorsLLCMember_z4uKp6TBL313" title="Percentage on contributed shares">100</span>% of the outstanding securities of Wealth Generators in exchange for an aggregate of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesOther_c20170329__20170401__us-gaap--TypeOfArrangementAxis__custom--ContributionAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--WealthGeneratorsLLCMember_zDYKCOpaSOL5" title="Number of shares exchanged for common stock">1,358,670,942</span> shares of our common stock. Following this transaction, Wealth Generators became our wholly owned subsidiary, and the former members of Wealth Generators became our stockholders and controlled the majority of our outstanding common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 6, 2017, we entered into an Acquisition Agreement with Market Trend Strategies, LLC, a company whose members are also former members of our management. Under the Acquisition Agreement, we spun-off our operations that existed prior to the merger with Wealth Generators and sold the intangible assets used in those pre-merger operations in exchange for Market Trend Strategies’ assumption of $<span id="xdx_903_eus-gaap--BusinessCombinationConsiderationTransferredLiabilitiesIncurred_c20170606__20170606__us-gaap--TypeOfArrangementAxis__custom--AcquisitionAgreementMember__dei--LegalEntityAxis__custom--MarketTrendStrategiesLLCMember_z5XTJ2uzR4nh" title="Value pre-merger liabilities">419,139</span> in pre-merger liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 28, 2018, we filed a name change for Wealth Generators, LLC to Kuvera, LLC (“Kuvera”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 17, 2019, we renamed our non-operating wholly owned subsidiary WealthGen Global, LLC to SAFETek, LLC, a Utah limited liability company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 11, 2021, we filed a name change for Kuvera, LLC to iGenius, LLC (“iGenius”) and on February 2, 2021, we filed a name change for Kuvera (N.I.) Limited to iGenius Global LTD.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 20, 2021, the Board of Directors approved a change in our fiscal year from March 31 to December 31.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nature of Business</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We operate a diversified financial technology company that through its subsidiaries and global distribution network provides financial technology, education tools, content, research, and a digital asset technology company, which develops, operates, and supports blockchain technologies, with a focus on the Bitcoin blockchain ecosystem and the generation of digital assets. In addition, we are planning to expand our business into the retail brokerage and financial markets industry by integrating the online brokerage trading platform we acquired in connection with our recent acquisition of Opencash, with the proprietary algorithmic trading platform we acquired in September 2021. Opencash is an early-stage registered broker-dealer that plans to offer investors an online trading platform to enable self-directed retail brokerage services and develop synergies with the educational content and products offered by other of our business units.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVESTVIEW, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DECEMBER 31, 2023 AND 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	1946-01-30
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_844_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zl6BOZuT3oM3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zwOLQNoKNGia">Financial Statement Reclassification</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain account balances from prior periods have been reclassified in these consolidated financial statements to conform to current period classifications.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84E_eus-gaap--UseOfEstimates_zQZN2aYWzJab" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_z2jR3eiljOra">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of these financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	21488898	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_z4etK8jcwEXg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zbdQCVyqBG27">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially expose us to concentration of credit risk include cash, accounts receivable, and advances. We place our cash and temporary cash investments with credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit of $<span id="xdx_90F_eus-gaap--CashFDICInsuredAmount_iI_c20231231_zUWVyPFIuRr6" title="Cash, FDIC insured amount">250,000</span>. As of December 31, 2023 and 2022, cash balances that exceeded FDIC limits were $<span id="xdx_902_ecustom--CashBalancesExceededFederalDepositInsuranceCorporationLimits_iI_c20231231_zdLxophjJMId" title="Cash balances exceeded FDIC limits">3,778,085</span> and $<span id="xdx_909_ecustom--CashBalancesExceededFederalDepositInsuranceCorporationLimits_iI_c20221231_zgMXUB264Hj6" title="Cash balances exceeded FDIC limits">18,202,860</span>, respectively. We have not experienced significant losses relating to these concentrations in the past.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	INVU	Cash Balances Exceeded Federal Deposit Insurance Corporation Limits CashBalancesExceededFederalDepositInsuranceCorporationLimits	3778085	usd
CY2022Q4	INVU	Cash Balances Exceeded Federal Deposit Insurance Corporation Limits CashBalancesExceededFederalDepositInsuranceCorporationLimits	18202860	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20912276	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20317253	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	230354	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	931540	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	240105	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	21142630	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	722324	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	719342	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	500000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	775000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	14096695	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13331052	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7559872	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4822778	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6536823	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8508274	usd
CY2023	us-gaap	Depreciation Depreciation	4450466	usd
CY2022	us-gaap	Depreciation Depreciation	6227907	usd
CY2023Q4	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment	26731	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	23278	usd
CY2023	INVU	Gain On Disposition Of Assets1 GainOnDispositionOfAssets1	6460	usd
CY2023	INVU	Loss On Disposition Of Assets1 LossOnDispositionOfAssets1	55255	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment	826718	usd
CY2022	us-gaap	Proceeds From Sale Of Other Property Plant And Equipment ProceedsFromSaleOfOtherPropertyPlantAndEquipment	1093556	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	266838	usd
CY2023Q4	INVU	Cryptocurrencies Cryptocurrencies	585632	usd
CY2022Q4	INVU	Cryptocurrencies Cryptocurrencies	2474096	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2360957	usd
CY2022Q4	us-gaap	Other Restricted Assets Noncurrent OtherRestrictedAssetsNoncurrent	113139	usd
CY2023	INVU	Realized Gain Loss On Cryptocurrency RealizedGainLossOnCryptocurrency	255268	usd
CY2022	INVU	Realized Gain Loss On Cryptocurrency RealizedGainLossOnCryptocurrency	-1575164	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2056386	usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	689822	usd
CY2023	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	0	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3419825	usd
CY2022	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	6026733	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7240000	usd
CY2023Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	5732	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	5732	usd
CY2022Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	24426	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	24426	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	2703398	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	2074574	usd
CY2022Q4	INVU	Customer Advance Current CustomerAdvanceCurrent	96609	usd
CY2023	INVU	Gross Billingsreceipts GrossBillingsreceipts	72879156	usd
CY2023	INVU	Refunds Incentives Credits And Chargebacks RefundsIncentivesCreditsAndChargebacks	-4480784	usd
CY2023	us-gaap	Payments To Suppliers PaymentsToSuppliers	477500	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	67920871	usd
CY2022	INVU	Gross Billingsreceipts GrossBillingsreceipts	66621347	usd
CY2022	INVU	Refunds Incentives Credits And Chargebacks RefundsIncentivesCreditsAndChargebacks	-3196649	usd
CY2022	us-gaap	Payments To Suppliers PaymentsToSuppliers	1575794	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	61848904	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	560065	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	58617	usd
CY2023	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	10736709	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	8249790	usd
CY2023	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	174835	usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	621093	usd
CY2022	us-gaap	Exploration Abandonment And Impairment Expense ExplorationAbandonmentAndImpairmentExpense	676268	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	249480	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2831920	usd
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	819340	usd
CY2023	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	900516	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2913096	usd
CY2023	INVU	Basic Weighted Average Number Of Common Shares Outstanding BasicWeightedAverageNumberOfCommonSharesOutstanding	2559093504	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	471428571	shares
CY2023	INVU	Incremental Common Shares Attributable To Dilutive Impact Of Nonvoting Membership Interest IncrementalCommonSharesAttributableToDilutiveImpactOfNonvotingMembershipInterest	565000000	shares
CY2023	INVU	Diluted Weighted Average Number Of Common Shares Outstanding Denominator DilutedWeightedAverageNumberOfCommonSharesOutstandingDenominator	3595522075	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1079569011	shares
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	4604930	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2831920	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20912276	usd
CY2023	INVU	Working Capital WorkingCapital	12414023	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	585632	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	477711	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	347782	usd
CY2023Q4	INVU	Convertible Notes Payable One ConvertibleNotesPayableOne	253566	usd
CY2022Q4	INVU	Convertible Notes Payable One ConvertibleNotesPayableOne	183020	usd
CY2023Q4	INVU	Convertible Notes Payable Two ConvertibleNotesPayableTwo	431072	usd
CY2022Q4	INVU	Convertible Notes Payable Two ConvertibleNotesPayableTwo	293779	usd
CY2023Q4	INVU	Working Capital Promissory Note Entered WorkingCapitalPromissoryNoteEntered	1203247	usd
CY2022Q4	INVU	Working Capital Promissory Note Entered WorkingCapitalPromissoryNoteEntered	1201927	usd
CY2020Q2	INVU	Related Party Transaction Amounts Of Advance RelatedPartyTransactionAmountsOfAdvance	11000000	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	1216189	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	8468403	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	715127	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2938757	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	501062	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	5529646	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	69371	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	44945	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	24426	usd
CY2023	INVU	Derivative Extinguished With Warrant Exercise DerivativeExtinguishedWithWarrantExercise	-3	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	18691	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	5732	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	156315	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	155032	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y1M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.12	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	116027	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	7833	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	123860	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	8184	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	115676	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	109628	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6048	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	252192	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	252192	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	252192	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	252192	shares
CY2023Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	256392	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	236630	usd
CY2023	INVU	Derivative Liability Extinguished With Warrant Exercise DerivativeLiabilityExtinguishedWithWarrantExercise	3	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	391279	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	46720	usd
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2333356496	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2333356496	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2636275489	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2636275489	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	68533334	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	218500000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward	360416665	shares
CY2022	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.05
CY2023	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	2555155	usd
CY2022	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	2392866	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1178320	shares
CY2021Q4	INVU	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	0.10
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1178320	shares
CY2022Q4	INVU	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	0.10
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	230	shares
CY2023	INVU	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Exercise Price Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceExercised	0.10
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1178090	shares
CY2023Q4	INVU	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	0.10
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.10
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1178090	shares
CY2022Q4	INVU	Warrants Exercisable WarrantsExercisable	1178090	shares
CY2022Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P2Y1M20D
CY2023	us-gaap	Common Stock Voting Rights CommonStockVotingRights	The Class B Redeemable Units have no voting rights but can be exchanged at any time, within 5 years from the date of issuance, for 565,000,000 shares of our common stock on a one-for-one basis and are subject to significant restrictions upon resale through 2025 under the terms of a lock up agreement entered into as part of the purchase agreement
CY2021Q3	INVU	Business Acquisition Cost Of Acquired Entity Transaction Fair Value Discount BusinessAcquisitionCostOfAcquiredEntityTransactionFairValueDiscount	27700000	usd
CY2023	us-gaap	Long Term Purchase Commitment Description LongTermPurchaseCommitmentDescription	According to marketing and legal documents provided by such third-party provider, the product protection would allow the purchaser to protect its initial purchase price by obtaining 50% of its purchase price at five years or 100% of its purchase price at ten years.
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.21	pure
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	5010332	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-12618389	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5010332	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12618389	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	2138412	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	52167	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	40000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	274388	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2178412	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	326555	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2178412	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	326555	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2982071	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4446991	usd
CY2023Q4	INVU	Deferred Tax Assets Amortization DeferredTaxAssetsAmortization	1771645	usd
CY2022Q4	INVU	Deferred Tax Assets Amortization DeferredTaxAssetsAmortization	1809500	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	1800662	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	821594	usd
CY2023Q4	INVU	Deferred Tax Assets Tax Deferred Expense Reserves And Investment In Partnership DeferredTaxAssetsTaxDeferredExpenseReservesAndInvestmentInPartnership	10964704	usd
CY2022Q4	INVU	Deferred Tax Assets Tax Deferred Expense Reserves And Investment In Partnership DeferredTaxAssetsTaxDeferredExpenseReservesAndInvestmentInPartnership	11029258	usd
CY2023Q4	INVU	Deferred Tax Liabilities Depreciation DeferredTaxLiabilitiesDepreciation	562982	usd
CY2022Q4	INVU	Deferred Tax Liabilities Depreciation DeferredTaxLiabilitiesDepreciation	-1734211	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	18082064	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16373132	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1052169	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2649862	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	31600	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	216767	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1809765	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1813044	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Fdii Amount EffectiveIncomeTaxRateReconciliationFdiiAmount	781561	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-13604	usd
CY2023	INVU	Income Tax Reconciliation Interest IncomeTaxReconciliationInterest	260317	usd
CY2022	INVU	Income Tax Reconciliation Interest IncomeTaxReconciliationInterest	556568	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-193878	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	403642	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2178412	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	326555	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	3000000.0	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	4400000	usd
CY2023Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd

Files In Submission

Name	View Source	Status
0001493152-24-011916-index-headers.html	Edgar Link	pending
0001493152-24-011916-index.html	Edgar Link	pending
0001493152-24-011916.txt	Edgar Link	pending
0001493152-24-011916-xbrl.zip	Edgar Link	pending
ex23-01.htm	Edgar Link	pending
ex23-01_001.jpg	Edgar Link	pending
ex3-06.htm	Edgar Link	pending
ex3-06_001.jpg	Edgar Link	pending
ex3-06_002.jpg	Edgar Link	pending
ex3-07.htm	Edgar Link	pending
ex3-07_001.jpg	Edgar Link	pending
ex3-07_002.jpg	Edgar Link	pending
ex3-07_003.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
invu-20231231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
invu-20231231_cal.xml	Edgar Link	unprocessable
invu-20231231_lab.xml	Edgar Link	unprocessable
invu-20231231_pre.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
invu-20231231_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INVU
Investview, Inc. Stock $invu

2024 Q1 Form 10-K Financial Statement

#000149315224011916 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INVU Investview, Inc. Stock $invu

2024 Q1 Form 10-K Financial Statement

#000149315224011916 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INVU
Investview, Inc. Stock $invu